Pyrazinamide and Pleurisy - a phase IV clinical study of FDA data

Summary:

Pleurisy is reported as a side effect among people who take Pyrazinamide (pyrazinamide), especially for people who are female, 50-59 old, also take Isoniazid, and have Hiv infection.

The phase IV clinical study analyzes which people have Pleurisy when taking Pyrazinamide. It is created by eHealthMe based on reports of 10,019 people who have side effects when taking Pyrazinamide from the FDA, and is updated regularly.

What is Pyrazinamide?

Pyrazinamide has active ingredients of pyrazinamide. It is often used in tuberculosis. eHealthMe is studying from 10,062 Pyrazinamide users. Check the latest studies of Pyrazinamide.

What is Pleurisy?

Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 813 drugs and 1,140 conditions by eHealthMe. Check the latest studies of Pleurisy.

On Jul, 18, 2026

10,019 people reported to have side effects when taking Pyrazinamide.
Among them, 19 people (0.19%) have Pleurisy.

Among these 19 people:

What is the gender of people who have Pleurisy when taking Pyrazinamide? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Pleurisy when taking Pyrazinamide? *

What are other drugs people take besides Pyrazinamide? *

What are other side effects people have besides Pleurisy? *

Pulmonary Tuberculosis (lungs tuberculosis): 8 people, 42.11%
Fever: 7 people, 36.84%
Rashes (redness): 7 people, 36.84%
Pericarditis (inflammation of the pericardium): 7 people, 36.84%
Itching: 5 people, 26.32%
Faeces Discolored: 5 people, 26.32%
Chest Pain: 5 people, 26.32%
Pulmonary Mass: 4 people, 21.05%
Lymphadenopathy Mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs): 2 people, 10.53%
Drug Ineffective: 2 people, 10.53%

What are the existing conditions these people have? *

Hiv Infection: 7 people, 36.84%
Pulmonary Tuberculosis (lungs tuberculosis): 6 people, 31.58%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 4 people, 21.05%
Tuberculous Pleurisy (an inflammation of lung covering plura by mycobacterium tuberculosis): 2 people, 10.53%
Pleural Effusion (water on the lungs): 2 people, 10.53%
Chronic Graft Versus Host Disease In Skin (damage by immune cells to skin after grafting): 2 people, 10.53%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.26%
Pneumonia: 1 person, 5.26%
Lymph Node Tuberculosis: 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pyrazinamide and have Pleurisy?

- Check whether Pleurisy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pyrazinamide:

Pyrazinamide (10,062 reports)

Pleurisy treatments and more:

Pleurisy (9,090 reports)

Browse all side effects of Pyrazinamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleurisy:

Pleurisy (813 drugs)

Browse all the conditions that are associated with Pleurisy:

Pleurisy (1,140 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pyrazinamide (the active ingredients of Pyrazinamide) and Pyrazinamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.